UBS Oncology Impact Fund LP

CIK 1691428 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for UBS Oncology Impact Fund LP.

Recent SEC filings

FiledFormAccession number
Jul 6, 20261440001628280-26-047364
Jun 29, 20261440001628280-26-046084
May 28, 20261440001628280-26-038893
May 18, 20261440001628280-26-036035
May 11, 20261440001628280-26-033567
May 1, 20261440001628280-26-029394
Apr 29, 20261440001628280-26-028438
Apr 27, 20261440001628280-26-027597
Jan 6, 20261440001628280-26-000951
Dec 29, 20251440001628280-25-059020
Dec 22, 20251440001628280-25-058567
Dec 10, 20251440001628280-25-056351
Dec 4, 202540001231919-25-000574
Dec 3, 20251440001628280-25-055072
Dec 1, 202540001231919-25-000564
Nov 25, 202540001231919-25-000550
Nov 24, 20251440001628280-25-053823
Nov 20, 202540001231919-25-000533
Nov 17, 202540001231919-25-000507
Nov 17, 20251440001628280-25-052648
Nov 6, 202540001231919-25-000439
Nov 4, 20251440001628280-25-048931
Nov 3, 202540001231919-25-000404
Oct 30, 20251440001628280-25-047588
Oct 29, 202540001231919-25-000373